1. A patient‐oriented risk–benefit analysis of pathogen‐inactivated blood components: application to apheresis platelets in the United States. Issue 7 (15th October 2012) Authors: Kleinman, Steven; Reed, William; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 53:Issue 7(2013) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease. Issue 6 (2nd April 2018) Authors: Castro, Grace; Merkel, Patricia A.; Giclas, Hannah E.; Gibula, Andrew; Andersen, Gillian E.; Corash, Laurence M.; Lin, Jin Sying; Green, Jennifer; Knight, Vijaya; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 6(2018) Page Start: 1506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amustaline (S‐303) treatment inactivates high levels of Zika virus in red blood cell components. Issue 3 (5th February 2017) Authors: Laughhunn, Andrew; Santa Maria, Felicia; Broult, Julien; Lanteri, Marion C.; Stassinopoulos, Adonis; Musso, Didier; Aubry, Maite Journal: Transfusion Issue: Volume 57:Issue 3(2017)Part 2 Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real‐time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA. Issue 2 (7th October 2015) Authors: Bakkour, Sonia; Chafets, Daniel M.; Wen, Li; Dupuis, Kent; Castro, Grace; Green, Jennifer M.; Stassinopoulos, Adonis; Busch, Michael P.; Lee, Tzong‐Hae Journal: Transfusion Issue: Volume 56:Issue 2(2016:Feb.) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bacterial safety of blood components–a congress review of the ISBT transfusion‐transmitted infectious diseases working party, bacterial subgroup. (18th March 2019) Authors: Ramirez‐Arcos, Sandra; McDonald, Carl; Deol, Parampal; Kreuger, Aukje L.; Patel, Nidhi; Pidcoke, Heather; Prax, Marcel; Seltsam, Axel; Stassinopoulos, Adonis Journal: ISBT science series Issue: Volume 14:Number 2(2018) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost implications of implementation of pathogen‐inactivated platelets. Issue 10 (18th May 2015) Authors: McCullough, Jeffrey; Goldfinger, Dennis; Gorlin, Jed; Riley, William J.; Sandhu, Harpreet; Stowell, Christopher; Ward, Dawn; Clay, Mary; Pulkrabek, Shelley; Chrebtow, Vera; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 55:Issue 10(2015) Page Start: 2312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light. Issue 6 (24th April 2020) Authors: Lanteri, Marion C.; Santa‐Maria, Felicia; Laughhunn, Andrew; Girard, Yvette A.; Picard‐Maureau, Marcus; Payrat, Jean‐Marc; Irsch, Johannes; Stassinopoulos, Adonis; Bringmann, Peter Journal: Transfusion Issue: Volume 60:Issue 6(2020) Page Start: 1319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inactivation of Babesia microti in red blood cells and platelet concentrates. Issue 10 (5th September 2017) Authors: Tonnetti, Laura; Laughhunn, Andrew; Thorp, Aaron M.; Vasilyeva, Irina; Dupuis, Kent; Stassinopoulos, Adonis; Stramer, Susan L. Journal: Transfusion Issue: Volume 57:Issue 10(2017) Page Start: 2404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione. Issue 3 (10th January 2018) Authors: Laughhunn, Andrew; Huang, Yan‐Jang S.; Vanlandingham, Dana L.; Lanteri, Marion C.; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 3(2018) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology. Issue 4 (4th March 2020) Authors: Sow, Cissé; Laughhunn, Andrew; Girard, Yvette A.; Lanteri, Marion C.; Amar El Dusouqui, Soraya; Stassinopoulos, Adonis; Grellier, Philippe Journal: Transfusion Issue: Volume 60:Issue 4(2020) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗